Nanosphere's Q2 Loss Rises on Expenses | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere reported after the close of the market Thursday that its second-quarter revenues increased around 28 percent, but its net loss jumped 64 percent on higher spending.

The Northbrook, Ill.-based molecular diagnostics firm brought in total revenues of $516,803 for the three-month period ended June 30, up from $402,237 for the second quarter of 2009. It fell short of analysts' consensus estimate for revenues of $880,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.